Search

Your search keyword '"J. Schwarz"' showing total 3,826 results

Search Constraints

Start Over You searched for: Author "J. Schwarz" Remove constraint Author: "J. Schwarz"
3,826 results on '"J. Schwarz"'

Search Results

1. Evaluation of the NAQFC driven by the NOAA Global Forecast System (version 16): comparison with the WRF-CMAQ during the summer 2019 FIREX-AQ campaign

2. Chemically speciated mass size distribution, particle density, shape and origin of non-refractory PM1 measured at a rural background site in central Europe

3. Mixed reality for teaching catheter placement to medical students: a randomized single-blinded, prospective trial

4. A multidisciplinary drought catalogue for southwestern Germany dating back to 1801

5. DEVELOPMENT OF RECOMBINANT ANTIGEN-BASED ELISA FOR THE DETECTION OF ANTI-TULAREMIA ANTIBODIES IN SWINE AND HUMAN SERA: A PILOT STUDY

6. Seasonal study of stable carbon and nitrogen isotopic composition in fine aerosols at a Central European rural background station

7. A European aerosol phenomenology - 7: High-time resolution chemical characteristics of submicron particulate matter across Europe

8. Integrating uncertainty propagation in GNSS radio occultation retrieval: from excess phase to atmospheric bending angle profiles

9. Self-generated surface magnetic fields inhibit laser-driven sheath acceleration of high-energy protons

10. An atlas of the aging mouse proteome reveals the features of age-related post-transcriptional dysregulation

11. The Cosmopolitan Club Movement at the University of Iowa

12. Atmospheric station Křešín u Pacova, Czech Republic – a Central European research infrastructure for studying greenhouse gases, aerosols and air quality

13. ECOC comparison exercise with identical thermal protocols after temperature offset correction – instrument diagnostics by in-depth evaluation of operational parameters

14. Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter Microstructure

15. Blood DNA methylation in post-acute sequelae of COVID-19 (PASC): a prospective cohort studyResearch in context

16. Soot reference materials for instrument calibration and intercomparisons: a workshop summary with recommendations

17. General overview: European Integrated project on Aerosol Cloud Climate and Air Quality interactions (EUCAARI) – integrating aerosol research from nano to global scales

18. Is flow velocity a significant parameter in flood damage modelling?

19. Enzymatic Transformation and Bonding of Sulfonamide Antibiotics to Model Humic Substances

20. Size resolved mass concentration and elemental composition of atmospheric aerosols over the Eastern Mediterranean area

21. Evolution of Lamayuru palaeolake in the Trans Himalaya: Palaeoecological implications

22. The assembly of the Mitochondrial Complex I Assembly complex uncovers a redox pathway coordination

23. Conceptual designs of two petawatt-class pulsed-power accelerators for high-energy-density-physics experiments

24. Machine learning-driven identification of the gene-expression signature associated with a persistent multiple organ dysfunction trajectory in critical illnessResearch in context

29. DDX58 Is Associated With Susceptibility to Severe Influenza Virus Infection in Children and Adolescents

30. Prognostic and Predictive Value of Endothelial Dysfunction Biomarkers in Sepsis-Associated Acute Kidney Injury: Risk Stratified Analysis from a Prospective Observational Cohort of Pediatric Septic Shock

31. Serum Soluble Endoglin in Pediatric Septic Shock Associated Multiple Organ Dysfunction Syndrome

32. A generalized approach to x-ray data modeling for high-energy-density plasma experiments

33. P911 The changes in the faecal microbiome and metabolome in Crohn's disease after treatment with anti-TNFα antibodies are of secondary origin

34. Desorden linfoproliferativo germinotrópico asociado al HHV8/KSVH y EBV

36. Selective THA-approach use amongst junior surgeons improves safety of introducing the anterior approach: a prospective, multi-surgeon, comparative, study

37. Supplementary Data Figure 1 from Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

38. Supplementary Data Figure 2 from Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

39. Supplementary Data Figure 5 from Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

40. Supplementary Data Figure 3 from Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

41. Supplementary Data Tables from Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

42. Supplementary Data Figure 7 from Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

43. Supplementary Data Figure 6 from Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

44. Supplementary Data Figure Legends from Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

45. Figure S4 from ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

46. Supplementary Tables from ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

47. Supplementary Data from ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

48. Data from Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER+/HER2+ Breast Cancers: Implications to the ExteNET Trial

49. Figures S1 and S2 from Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER+/HER2+ Breast Cancers: Implications to the ExteNET Trial

50. Data from ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

Catalog

Books, media, physical & digital resources